Evidence map›Paper›PMID 26001326›Full record

ArticleGynecologic oncology2015

HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.

Marina Frimer, Chang Sun, Thomas McAndrew, Benjamin Smith, Ariana Harari, Zigui Chen, Lisa Mirabello, Nicolas Wentzensen, Gary L Goldberg, Ana C Rodriguez and 2 more

Abstract read
In one paragraph

Article in Gynecologic oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Effects of CpG sites methylation modification of HPV16 integration essential gene on the proliferation of cervical cancer cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  5. Genetic and Epigenetic Variations of HPV52 in Cervical Precancer.International journal of molecular sciences · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marina FrimerDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, United States. Electronic address: mfrimer@montefiore.org.
Chang SunDepartment of Pediatrics, Albert Einstein College of Medicine, United States.
Thomas McAndrewDepartment of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, United States.
Benjamin SmithDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, United States.
Ariana HarariDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, United States.
Zigui ChenDepartment of Pediatrics, Albert Einstein College of Medicine, United States.
Lisa MirabelloDivision of Cancer Epidemiology and Genetics, National Cancer Institute, United States.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, United States.
Gary L GoldbergDivision of Gynecologic Oncology, Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, United States.
Ana C RodriguezProyecto Epidemiologico Guanacaste, Fundacion INCIENSA, San Jose, Costa Rica.
Mark SchiffmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, United States.
Robert D BurkDepartment of Pediatrics, Albert Einstein College of Medicine, United States; Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, United States; Department of Microbiology and Immunology, Albert Einstein College of Medicine, United States.

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Human Papillomavirus (HPV) Natural History, Genomics and Risk AssessmentZIACP010206 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SCHIFFMAN, MARK · 2010 to 2025
$17.1M
PERSISTENT HUMAN PAPILLOMAVIRUS IN WOMEN AT RISK FOR CERVIX CANCERU01CA078527 · NCI · YESHIVA UNIVERSITY · PI BURK, ROBERT D · 2003 to 2018
$8.6M
PERSISTENT HPV IN WOMEN AT RISK FOR CERVIX CANCERR01CA078527 · NCI · YESHIVA UNIVERSITY · PI BURK, ROBERT D. · 1998 to 2002
$1.5M
NCI NIH HHS CA78527NCI NIH HHS P30 CA013330NCI NIH HHS P30CA013330NCI NIH HHS R01 CA078527NCI NIH HHS U01 CA078527NIAID NIH HHS AI-51519NIAID NIH HHS P30 AI051519
6 · The paper itself

Abstract

objectiveTo evaluate HPV16 CpG methylation and methyl-haplotypes and their association with cervix precancer and cancer utilizing massively parallel single molecule next-generation sequencing (NGS).

methodsA nested case-control study of HPV16 positive women was performed in a prospective cohort from Guanacaste, Costa Rica designed to study the natural history of HPV and cervical neoplasia. Controls encompassed 31 women with transient infections; there were 44 cases, including 31 women with CIN3 and 13 with cervical cancer. DNA samples from exfoliated cervical cells were treated with bisulfite and four regions (E6, E2, L2 and L1) were amplified with barcoded primers and tested by NGS. CpG methylation was quantified using a bioinformatics pipeline.

resultsMedian methylation levels were significantly different between the CIN3+ cases versus controls in the E2, L2, and L1 regions. Methyl-haplotypes, specifically in 5 CpG sites included in the targeted L2 region, with the pattern "--+-+" had the highest Area Under the Curve value (AUC=88.40%) observed for CIN3 vs. CONTROLS: The most significant CpG site, L2 4277, determined by bisulfite NGS had an AUC=78.62%.

conclusionsThis study demonstrates that NGS of bisulfite treated HPV DNA is a useful and efficient technique to survey methylation patterns in HPV16. This procedure provides quantitative information on both individual CpG sites and methyl-haplotypes that identify women with elevated present or subsequent risk for HPV16 CIN3 and cancer.

Indexed as

CpG IslandsDNA MethylationAdultCase-Control StudiesCosta RicaDNA, NeoplasmDNA, ViralFemaleHaplotypesHuman papillomavirus 16HumansLongitudinal StudiesPapillomavirus InfectionsSequence Analysis, DNASulfitesUterine Cervical DysplasiaDNA, NeoplasmDNA, Viralhydrogen sulfiteSulfitesCervix cancerDNA methylationHPV16Next generation sequencing

Identifiers

PMID26001326
PMCPMC4867226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.